Danielle Toal, APRN
Primary Care · Cape Girardeau, MONPI 1346781069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 618 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 618 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$1K
- UCB, Inc.$1K
- Novartis$1K
- LEO Pharma Inc.$924
- plus $6K from 24 others
What the payments were for
- Food & beverage$14,04895%
- Education$7235%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 134 | $2,989 |
| Johnson & Johnson | 66 | $1,554 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,479 |
| UCB, Inc. | 35 | $1,203 |
| Novartis | 53 | $1,114 |
| LEO Pharma Inc. | 40 | $924 |
| Amgen | 26 | $782 |
| Lilly USA, LLC | 40 | $753 |
| E.r. Squibb & Sons, L.L.C. | 37 | $670 |
| Sun Pharmaceutical Industries Inc. | 19 | $510 |
| Dermavant Sciences, Inc. | 27 | $399 |
| Sanofi | 17 | $379 |
| AstraZeneca | 4 | $347 |
| Pfizer | 16 | $287 |
| Galderma Laboratories, L.p. | 14 | $247 |
| Incyte Corporation | 9 | $211 |
| Strata Skin Sciences, Inc. | 1 | $153 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $127 |
| Arcutis Biotherapeutics, Inc. | 6 | $97 |
| Botanix SB Inc | 5 | $90 |
| Almirall LLC | 5 | $87 |
| Convatec Inc. | 3 | $79 |
| Genentech USA, Inc. | 4 | $74 |
| Organon | 5 | $58 |
| Merck | 2 | $39 |
| Fresenius Kabi USA, LLC | 2 | $33 |
| Boehringer Ingelheim | 1 | $30 |
| Biofrontera Inc. | 2 | $23 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,772 in reported general payments places this provider in the 95th percentile of 106 primary care providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 16 | $327,312 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 30 | $233,415 |
| XolairOmalizumab | 12 | $38,491 |
| Clobetasol Propionate | 131 | $6,905 |
| Ketoconazole | 233 | $3,330 |
| Fluorouracil | 29 | $2,076 |
| Doxycycline Hyclate | 68 | $1,739 |
| Triamcinolone Acetonide | 179 | $1,009 |
| Tacrolimus | 12 | $918 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 13 | $833 |
| Metronidazole | 14 | $816 |
| Fluticasone Propionate | 27 | $503 |
| Hydroxychloroquine Sulfate | 19 | $499 |
| Nystatin | 41 | $497 |
| Betamethasone Dipropionate | 11 | $484 |
Paid to pharmacies, not to this prescriber.
Other primary care in Cape Girardeau
- Cassidy HensonCape Girardeau$851
- Violet de la CruzCape Girardeau$557
- Joy MurphySaint Louis$7K
- Katrina SelsorSparta$6K
- Kelly EspositoSaint Louis$6K
- Elizabeth YoungSaint Louis$5K
- Carol HarringtonIndependence$4K
- Melanie HenryHayti$4K
- Heather BealSaint Louis$4K
- Taylor HeathSparta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.